UK Markets closed

Cyteir Therapeutics, Inc. (CYT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.53-0.30 (-5.15%)
At close: 04:00PM EST
5.53 0.00 (0.00%)
After hours: 04:01PM EST
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 323.10
52-week low 35.43
50-day moving average 311.78
200-day moving average 316.19

Share statistics

Avg vol (3-month) 384.92k
Avg vol (10-day) 3170.6k
Shares outstanding 535.37M
Implied shares outstanding 6N/A
Float 811.87M
% held by insiders 14.29%
% held by institutions 156.45%
Shares short (30 Dec 2021) 42.39M
Short ratio (30 Dec 2021) 426.89
Short % of float (30 Dec 2021) 410.15%
Short % of shares outstanding (30 Dec 2021) 46.75%
Shares short (prior month 29 Nov 2021) 42.25M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-16.59M
EBITDA -35.34M
Net income avi to common (ttm)-35.67M
Diluted EPS (ttm)-3.20
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)199.82M
Total cash per share (mrq)5.69
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)27.12
Book value per share (mrq)5.64

Cash flow statement

Operating cash flow (ttm)-31.57M
Levered free cash flow (ttm)N/A